Security key
29772L108
Eton Pharmaceuticals, Inc. - Common Stock (ETON)
CUSIP: 29772L108
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 113
- Total 13F value
- $4,090
- Share change
- +113
- SEC-reported price per share
- $36.19
- Number of holders
- 2
- Value change
- +$4,090
- Number of buys
- 2
- Shares outstanding
- 26,828,643
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
ETON full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Eton Pharmaceuticals, Inc. SEC filings
Eton Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29772L108
Recent filing periods:
Ownership snapshot
Top reported holders of ETON - Eton Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F
13D/G
3/4/5
Lead comparable stake: 7.7%
13D/G row: EcoR1 Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
EcoR1 Capital, LLC leads the comparable SEC ownership view at 7.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens EcoR1 Capital, LLC's linked filing trail.
Comparable ownership
Top 5
EcoR1 Capital, LLC
7.7%
BlackRock, Inc.
5.7%
Opaleye Management Inc.
11%
Nantahala Capital Management, LLC
4.4%
VANGUARD CAPITAL MANAGEMENT LLC
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC |
13F
13D/G
Company
|
7.7%
from 13D/G
|
$53,603,430
2,171,938 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$42,382,617
1,717,286 shares
|
— | 31 Mar 2026 |
| Opaleye Management Inc. |
13F
3/4/5
Company · 10%+ Owner
|
11%
from 3/4/5
|
$70,584,800
2,860,000 shares
|
— | 31 Mar 2026 |
| Nantahala Capital Management, LLC |
13F
Company
|
4.4%
|
$29,022,471
1,175,951 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
3.7%
|
$24,534,117
994,089 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.2%
|
$14,260,695
577,666 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
113
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
115
Q2 2026 holders
2
Holder diff
-113
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend